Ceva
    Worldwide
    CLOSE

    Collaboration in more than 46 countries.

    You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

    A TECHNICAL - ECONOMICAL BOOKLET OF VECTORMUNE® ND FOR

    Newcastle Disease Vaccination

    In this booklet, you will find an updated technical-economic summary for Ceva’s ND vaccine solutions, containing recent field trials performed in 21 countries worldwide.

    Each field trial includes an economic calculation, based on a specific and updated scale, which suggests the approximate value of using Ceva’s ND vaccine solutions.

    These field trials compare Vectormune®ND versus live or killed ND vaccines or absence of ND vaccination, or competitor’s rHVT-ND vaccines.

    Ceva Santé Animale is committed to sharing information and updated field data with partners and customers.


    Enjoy your reading.

    TABLE OF CONTENTS

    • 1. What is Newcastle disease (ND)?

    • 2. Why is ND still a threat to the poultry industry?

    • 3. What does a proper vaccination program look like?

    • 4. What is Vectormune® ND?

    • 5. What are the benefits of Vectormune® ND prevention program?

    • 6. Improvements in performance: field and processing data

    • 7. Summary of profitability
    Booklet page 1
    This is a description
    Booklet page 2
    Booklet page 3

    Download your free copy